These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1969897)

  • 21. Salivary gland tumors among atomic bomb survivors, 1950-1987.
    Saku T; Hayashi Y; Takahara O; Matsuura H; Tokunaga M; Tokunaga M; Tokuoka S; Soda M; Mabuchi K; Land CE
    Cancer; 1997 Apr; 79(8):1465-75. PubMed ID: 9118025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Somatic cell mutations at the glycophorin A locus in erythrocytes of atomic bomb survivors: implications for radiation carcinogenesis.
    Kyoizumi S; Akiyama M; Cologne JB; Tanabe K; Nakamura N; Awa AA; Hirai Y; Kusunoki Y; Umeki S
    Radiat Res; 1996 Jul; 146(1):43-52. PubMed ID: 8677297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on the Hiroshima and Nagasaki survivors, and their use in estimating radiation risks.
    Muirhead CR
    Radiat Prot Dosimetry; 2003; 104(4):331-5. PubMed ID: 14579889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Risk of postirradiation induction of cancer of the modern methods of radiotherapy (3D CRT and IMRT) head and neck cancer].
    Milecki P; Szyfter K; Skowronek J
    Otolaryngol Pol; 2004; 58(5):887-93. PubMed ID: 15732771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thyroid Dysfunction and Autoimmune Thyroid Diseases Among Atomic Bomb Survivors Exposed in Childhood.
    Imaizumi M; Ohishi W; Nakashima E; Sera N; Neriishi K; Yamada M; Tatsukawa Y; Takahashi I; Fujiwara S; Sugino K; Ando T; Usa T; Kawakami A; Akahoshi M; Hida A
    J Clin Endocrinol Metab; 2017 Jul; 102(7):2516-2524. PubMed ID: 28472357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lung cancer mortality between 1950 and 1987 after exposure to fractionated moderate-dose-rate ionizing radiation in the Canadian fluoroscopy cohort study and a comparison with lung cancer mortality in the Atomic Bomb survivors study.
    Howe GR
    Radiat Res; 1995 Jun; 142(3):295-304. PubMed ID: 7761580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ionizing radiation: future etiologic research and preventive strategies.
    Darby SC; Inskip PD
    Environ Health Perspect; 1995 Nov; 103 Suppl 8(Suppl 8):245-9. PubMed ID: 8741792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ionizing radiation and cancer risk: evidence from epidemiology.
    Ron E
    Radiat Res; 1998 Nov; 150(5 Suppl):S30-41. PubMed ID: 9806607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk estimates for radiation-induced cancer--the epidemiological evidence.
    Kellerer AM
    Radiat Environ Biophys; 2000 Mar; 39(1):17-24. PubMed ID: 10789891
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reassessment of the cancer mortality risk among Hiroshima atomic-bomb survivors using a new dosimetry system, ABS2000D, compared with ABS93D.
    Katayama H; Matsuura M; Endo S; Hoshi M; Ohtaki M; Hayakawa N
    J Radiat Res; 2002 Mar; 43(1):53-64. PubMed ID: 12056330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Diagnostic radiation and the risk of cancer].
    Kai M
    Gan To Kagaku Ryoho; 2005 Sep; 32(9):1229-34. PubMed ID: 16184914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Radiation risks. Results of the new evaluation].
    Kellerer AM
    Radiologe; 1991 May; 31(5):227-34. PubMed ID: 1876693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dose response and temporal patterns of radiation-associated solid cancer risks.
    Preston DL; Pierce DA; Shimizu Y; Ron E; Mabuchi K
    Health Phys; 2003 Jul; 85(1):43-6. PubMed ID: 12852470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple myeloma among atomic bomb survivors in Hiroshima and Nagasaki, 1950-76: relationship to radiation dose absorbed by marrow.
    Ichimaru M; Ishimaru T; Mikami M; Matsunaga M
    J Natl Cancer Inst; 1982 Aug; 69(2):323-8. PubMed ID: 6955540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term effects of radiation exposure on health.
    Kamiya K; Ozasa K; Akiba S; Niwa O; Kodama K; Takamura N; Zaharieva EK; Kimura Y; Wakeford R
    Lancet; 2015 Aug; 386(9992):469-78. PubMed ID: 26251392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence of female breast cancer among atomic bomb survivors, Hiroshima and Nagasaki, 1950-1980.
    Tokunaga M; Land CE; Yamamoto T; Asano M; Tokuoka S; Ezaki H; Nishimori I
    Radiat Res; 1987 Nov; 112(2):243-72. PubMed ID: 3685255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thermoluminescence dosimetry of gamma rays using ceramic samples from Hiroshima and Nagasaki: a comparison with DS86 estimates.
    Nagatomo T; Ichikawa Y; Hoshi M
    J Radiat Res; 1991 Mar; 32 Suppl():48-57. PubMed ID: 1762131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A framework for estimating radiation-related cancer risks in Japan from the 2011 Fukushima nuclear accident.
    Walsh L; Zhang W; Shore RE; Auvinen A; Laurier D; Wakeford R; Jacob P; Gent N; Anspaugh LR; Schüz J; Kesminiene A; van Deventer E; Tritscher A; del Rosarion Pérez M
    Radiat Res; 2014 Nov; 182(5):556-72. PubMed ID: 25251702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biokinetic and dosimetric modelling in the estimation of radiation risks from internal emitters.
    Harrison J
    J Radiol Prot; 2009 Jun; 29(2A):A81-A105. PubMed ID: 19454809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High incidence of meningioma among Hiroshima atomic bomb survivors.
    Shintani T; Hayakawa N; Hoshi M; Sumida M; Kurisu K; Oki S; Kodama Y; Kajikawa H; Inai K; Kamada N
    J Radiat Res; 1999 Mar; 40(1):49-57. PubMed ID: 10408177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.